NCT07328685 Basic Body Awareness Therapy in Individuals With Migraine
| NCT ID | NCT07328685 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mustafa Kemal University |
| Condition | Migraine |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-02 |
| Primary Completion | 2026-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-02 with a primary completion date of 2026-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the Jenkins Sleep Scale (JUS), and quality of life using the Headache Impact Test. Assessment of functional status, sleep quality, and quality of life will be performed before treatment and after treatment (at the end of week 8).
Eligibility Criteria
Inclusion Criteria: * Diagnosed with migraine, * Experiencing at least 3 migraine attacks per month, * Between the ages of 18 and 55 and who volunteer to participate in the study. Exclusion Criteria: * History of secondary headaches, * Being pregnant, * Having any other neurological disease besides migraine, * Having other secondary headaches in addition to migraine, * History of malignancy, * Regularly practicing meditation, yoga, or mindfulness-based practices.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07328685 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Migraine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07328685 currently recruiting?
Yes, NCT07328685 is actively recruiting participants. Contact the research team at ptyasemindeveci@gmail.com for enrollment information.
Where is the NCT07328685 trial being conducted?
This trial is being conducted at Antakya, Turkey (Türkiye).
Who is sponsoring the NCT07328685 clinical trial?
NCT07328685 is sponsored by Mustafa Kemal University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.